Abstract
Transforming growth factor-β1 (TGF-β1) can act as both a tumor suppressor and a stimulator of tumor progression. We have examined the relationship between polymorphisms of the TGF-β1 gene and the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B virus (HBV) infection. A total of 1,237 Korean subjects were prospectively enrolled; 1,046 patients with chronic HBV infection and 191 healthy controls with no evidence of recent or remote HBV infection. The patients were divided into two groups: those without (n=809) and those with HCC (n=237). Single nucleotide polymorphisms (SNPs) of TGF-β1 were searched for and genotyped using the single base extension method. In Korean subjects, only two SNPs were found among the seven known polymorphisms of TGF-β1, at position -509 and in codon 10. The risk of HCC was significantly lower in patients with the T/T or C/T genotypes than in those with the C/C genotypes at position -509 (P<0.02), and also lower among those with the Pro/Pro or Leu/Pro genotypes than in those with the Leu/Leu genotypes in codon 10 (P<0.007). Haplotype analysis revealed that the possession of [-509C>T; L10P] conferred a decreased likelihood of HCC (OR=0.74; 95% CI, 0.59-0.93; P=0.008). In conclusion, the presence of the TGF-β1 -509C>T promoter or of the L10P polymorphism, and the combination of both [-509C>T; L10P] as a haplotype were strongly associated with a reduced risk of HCC in patients with chronic HBV infection.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Kim, Y., Lee, HS., Im, J. et al. Association of transforming growth factor-β1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection. Exp Mol Med 35, 196–202 (2003). https://doi.org/10.1038/emm.2003.27
Published:
Issue Date:
DOI: https://doi.org/10.1038/emm.2003.27
Keywords
This article is cited by
-
No association between TGF-β1 polymorphisms and risk of nasopharyngeal carcinoma in a large North African case-control study
BMC Medical Genetics (2016)
-
Association of TGF-β1 -509C/T polymorphisms with breast cancer risk: evidence from an updated meta-analysis
Tumor Biology (2014)
-
Polymorphisms of VEGF, TGFβ1, TGFβR2 and conotruncal heart defects in a Chinese population
Molecular Biology Reports (2014)
-
TGF-β1 −509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk
Tumor Biology (2013)
-
TGF beta1 and related-Smads contribute to pulmonary metastasis of hepatocellular carcinoma in mice model
Journal of Experimental & Clinical Cancer Research (2012)